Malnique, Fabricio, et al. “USE OF DAPAGLIFLOZIN (FORXIGA) IN THE MANAGEMENT OF OBESITY AND NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES”. Seven Editora, Nov. 2025, pp. 368-79, https://sevenpubl.com.br/editora/article/view/8517.